Riley Wyberg

ID: 1b826635-2619-30fb-68c4

/

Unclaimed

/

Organization: Goodwin Procter

FDA Issues Guidance on Modernizing Statistical Methods for Clinical Trials

Big Molecule Watch · February 4, 2026

FDA Approves mAbxience and Amneal’s Denosumab Biosimilars

Big Molecule Watch · December 24, 2025

Biocon and Regeneron Enter Global Settlement on Aflibercept Biosimilar

Big Molecule Watch · December 24, 2025

Sandoz and EirGenix Enter Licensing Agreement to Commercialize Proposed Pertuzumab Biosimilar

Big Molecule Watch · November 24, 2025

FDA Approves Shanghai Henlius’s Interchangeable Pertuzumab Biosimilar

Big Molecule Watch · November 14, 2025